Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3255)
All Articles published online
|
Dec 21, 2008 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang HN, Wang YR, Liu GQ, Liu Z, Wu PX, Wei XL, Hong TP. Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. World J Gastroenterol 2008; 14(47): 7240-7246 [PMID: 19084941 DOI: 10.3748/wjg.14.7240] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i47/7240.htm |
| Number | Citing Articles |
| 1 |
Xiaolei Zhou, Shengyi You. Rosiglitazone Inhibits Hepatic Insulin Resistance Induced by Chronic Pancreatitis and IKK-β/NF-κB Expression in Liver. Pancreas 2014; 43(8): 1291 doi: 10.1097/MPA.0000000000000173
|
| 2 |
Safaa M. Shaker, Yosra M. Magdy, Lobna F. Abd-Elaziz, Sawsan A. El-Said, Omnia A. Alkharashy, Enas S. Nabeeh. Histological study on the effect of metformin on high-fat-diet-induced liver injury in adult male albino rats. The Egyptian Journal of Histology 2014; 37(3): 592 doi: 10.1097/01.EHX.0000452726.54766.93
|
| 3 |
Feng Zhou, Ying Zhang, Jing Chen, Yimeng Hu, Yancheng Xu. Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00640
|
| 4 |
Xi Chen, Xin-Rui Tan, Shi-Jun Li, Xing-Xing Zhang. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease. Life Sciences 2019; 235: 116829 doi: 10.1016/j.lfs.2019.116829
|
| 5 |
Xinli Li, Fuzhi Lian, Chun Liu, Kang-Quan Hu, Xiang-Dong Wang. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice. Scientific Reports 2015; 5(1) doi: 10.1038/srep16774
|
| 6 |
Yosra M. Magdy, Omnyah A. El-Kharashi, Enas S. Nabih, Safaa M. Shaker, Lobna F. Abd-Elaziz, Sawsan Aboul-Fotouh. Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress. Biomedicine & Pharmacotherapy 2017; 85: 225 doi: 10.1016/j.biopha.2016.10.098
|
| 7 |
Onpan Cheung, Arun J. Sanyal. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 499 doi: 10.1007/978-1-4419-7107-4_34
|
| 8 |
Abdullah Al Mamun, Yanqing Wu, Chang Jia, Fahad Munir, Kasfia Jahan Sathy, Tamanna Sarker, Ilma Monalisa, Kailiang Zhou, Jian Xiao. Role of pyroptosis in liver diseases. International Immunopharmacology 2020; 84: 106489 doi: 10.1016/j.intimp.2020.106489
|
| 9 |
Xiaoming Yin, Yang Guo, Weiguo Li, Eugene Huo, Zhuoli Zhang, Jodi Nicolai, Robert A. Kleps, Diego Hernando, Aggelos K. Katsaggelos, Reed A. Omary, Andrew C. Larson. Chemical Shift MR Imaging Methods for the Quantification of Transcatheter Lipiodol Delivery to the Liver: Preclinical Feasibility Studies in a Rodent Model. Radiology 2012; 263(3): 714 doi: 10.1148/radiol.12111916
|
| 10 |
Sara A. Khedr, Ahmed A. Elmelgy, Omnyah A. El-Kharashi, Hadwa A. Abd-Alkhalek, Manal L. Louka, Hoda A. Sallam, Sawsan Aboul-Fotouh. Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-Jun repression. Naunyn-Schmiedeberg's Archives of Pharmacology 2018; 391(4): 407 doi: 10.1007/s00210-018-1466-8
|
| 11 |
Yunfu Sun, Yu Song, Changsheng Liu, Jianli Geng. LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling. Biochemical and Biophysical Research Communications 2019; 516(2): 584 doi: 10.1016/j.bbrc.2019.06.104
|
| 12 |
Arun J. Sanyal. An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis. Hepatology International 2013; 7(S2): 800 doi: 10.1007/s12072-013-9479-3
|
| 13 |
Zeyu Miao, Xiaorong Zhang, Yang Xu, Yan Liu, Qing Yang. Unveiling the nexus: pyroptosis and its crucial implications in liver diseases. Molecular and Cellular Biochemistry 2024; doi: 10.1007/s11010-024-05147-1
|
| 14 |
Tomohiro Ogawa, Hideki Fujii, Katsutoshi Yoshizato, Norifumi Kawada. A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in Rabbits. The American Journal of Pathology 2010; 177(1): 153 doi: 10.2353/ajpath.2010.090895
|
| 15 |
Amanda Karolina Soares e Silva, Dilênia de Oliveira Cipriano Torres, Fabiana Oliveira dos Santos Gomes, Bruna dos Santos Silva, Edlene Lima Ribeiro, Amanda Costa Oliveira, Laise Aline Martins dos Santos, Maria do Carmo Alves de Lima, Ivan da Rocha Pitta, Christina Alves Peixoto, Patricia Aspichueta. LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD). PLOS ONE 2015; 10(4): e0123787 doi: 10.1371/journal.pone.0123787
|
| 16 |
XIULI LI, JIN LI, XIAOLAN LU, HUIHUI MA, HAITAO SHI, HONG LI, DANHONG XIE, LEI DONG, CHUNLIAN LIANG. Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model. International Journal of Molecular Medicine 2015; 36(3): 767 doi: 10.3892/ijmm.2015.2270
|
| 17 |
Onpan Cheung, Arun J Sanyal. Recent advances in nonalcoholic fatty liver disease. Current Opinion in Gastroenterology 2009; 25(3): 230 doi: 10.1097/MOG.0b013e3283294a18
|
| 18 |
A.P. Ross, E.C. Bruggeman, A.W. Kasumu, J.G. Mielke, M.B. Parent. Non-alcoholic fatty liver disease impairs hippocampal-dependent memory in male rats. Physiology & Behavior 2012; 106(2): 133 doi: 10.1016/j.physbeh.2012.01.008
|
| 19 |
Rohini Mehta, Arpan Neupane, Lei Wang, Zachary Goodman, Ancha Baranova, Zobair M Younossi. Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects. BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0208-8
|
| 20 |
Shuntarou Tsuchiya, Yuichiro Amano, Osamu Isono, Mayumi Imai, Fumi Shimizu, Mari Asada, Shigemitsu Imai, Ayako Harada, Yoshitaka Yasuhara, Ryuichi Tozawa, Hiroshi Nagabukuro. Pharmacological evaluation of pioglitazone and candesartan cilexetil in a novel mouse model of non‐alcoholic steatohepatitis, modified choline‐deficient, amino acid‐defined diet fed low‐density lipoprotein receptor knockout mice. Hepatology Research 2017; 47(6): 584 doi: 10.1111/hepr.12773
|
| 21 |
Claudia Sedlinsky, María Silvina Molinuevo, Ana María Cortizo, María José Tolosa, Juan Ignacio Felice, María Laura Sbaraglini, Leon Schurman, Antonio Desmond McCarthy. Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats. European Journal of Pharmacology 2011; 668(3): 477 doi: 10.1016/j.ejphar.2011.07.033
|
| 22 |
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
|
| 23 |
Ibrahim H. Borai, Yehia Shaker, Maha Moustafa Kamal, Wafaa M. Ezzat, Esmat Ashour, Mie Afify, Weaam Gouda, Maha M. Elbrashy. Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2017; 5(2): 109 doi: 10.14218/JCTH.2017.00004
|
| 24 |
Kazuki Mochizuki, Yu Tan, Yumiko Uchiyama, Takuji Suzuki, Natsuyo Hariya, Toshinao Goda. Supplementation with lower doses of EGCg reduces liver injury markers of type 2 diabetic rats. Fundamental Toxicological Sciences 2019; 6(1): 15 doi: 10.2131/fts.6.15
|
| 25 |
Milos Lazic, Maria Eugenia Inzaugarat, Davide Povero, Iris C. Zhao, Mark Chen, Madlena Nalbandian, Yury I. Miller, Alejandra C. Cherñavsky, Ariel E. Feldstein, Dorothy D. Sears, Marcia B. Aguila. Reduced Dietary Omega-6 to Omega-3 Fatty Acid Ratio and 12/15-Lipoxygenase Deficiency Are Protective against Chronic High Fat Diet-Induced Steatohepatitis. PLoS ONE 2014; 9(9): e107658 doi: 10.1371/journal.pone.0107658
|
| 26 |
Shinnosuke Kondo, Natsuyo Hariya, Kazuki Mochizuki. High-dose β-carotene exacerbates high-fat/high-sucrose diet-inducible fibrosis in the liver of Mongolian gerbils. Fundamental Toxicological Sciences 2019; 6(6): 235 doi: 10.2131/fts.6.235
|